Analysis of the role of conserved cysteine residues in the Bcl-2 oncoprotein

被引:6
|
作者
Maser, RS
Antoku, K
Scully, WJ
Cho, RL
Johnson, DE
机构
[1] Univ Pittsburgh, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA
关键词
Bcl-2; Bax; apoptosis; cysteine; caspase; yeast two-hybrid;
D O I
10.1006/bbrc.2000.3652
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Bcl-2 oncoprotein is an integral membrane protein localized primarily to the outer membrane of the mitochondria. The precise molecular mechanism responsible for the antiapoptotic action of Bcl-2 remains unknown. Two cysteine residues are found in Bcl-2 and these residues are well-conserved across species. The first cysteine (cys(155)) is located in the alpha5 domain, a region important for the ion channel properties of Bcl-2, while the second cysteine (cys(226)) is located in the carboxyl-terminal membrane anchor domain. In this study, we found that replacement of both cysteines with serine residues generated a mutant protein that retained the ability to homodimerize and heterodimerize with proapoptotic Bax protein in vitro. In whole cells, the mutant protein efficiently heterodimerized with Bax, but exhibited impaired homodimerization relative to wild-type Bcl-2. The mutant protein was also less efficient than wild-type Bcl-2 at suppressing caspase activation, DNA fragmentation, and loss of viability during IL-3 withdrawal-induced apoptosis. Together, the data indicate that the cysteine residues in Bcl-2 contribute, but are not absolutely essential, to the ability of Bcl-2 to homodimerize, heterodimerize with Bax, and suppress apoptosis, (C) 2000 Academic Press.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [1] BCL-2 ONCOPROTEIN IN NEUROBLASTOMA
    WEINREB, M
    DAY, PJR
    NIGGLI, F
    RAAFAT, F
    MANN, JR
    LANCET, 1995, 345 (8955): : 992 - 993
  • [2] Expression of the bcl-2 oncoprotein in meningiomas
    Mosnier, JF
    Perret, AG
    Brunon, J
    Boucheron, S
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 106 (05) : 652 - 659
  • [3] THE BCL-2 ONCOPROTEIN FUNCTIONS AS A PROOXIDANT
    STEINMAN, HM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (08) : 3487 - 3490
  • [4] BCL-2 ONCOPROTEIN EXPRESSION AND APOPTOSIS IN NEUROBLASTOMA
    IKEDA, H
    HIRATO, J
    AKAMI, M
    MATSUYAMA, S
    SUZUKI, N
    TAKAHASHI, A
    KUROIWA, M
    JOURNAL OF PEDIATRIC SURGERY, 1995, 30 (06) : 805 - 808
  • [5] ANALYSIS OF THE ROLE OF BCL-2 IN APOPTOSIS
    HAWKINS, CJ
    VAUX, DL
    IMMUNOLOGICAL REVIEWS, 1994, 142 : 127 - 139
  • [6] The immunohistochemical expression of BCL-2 oncoprotein in colorectal adenocarcinoma
    Naoto Ishijima
    Chikao Miki
    Tomomi Ishida
    Tsuneki Kinoshita
    Hiroshi Suzuki
    Surgery Today, 1999, 29 : 682 - 684
  • [7] Pulmonary paraganglioid carcinoids and bcl-2 oncoprotein expression
    M. Reěl
    I. Friedmann
    J. Šimek
    V. Chrobok
    J. Bukač
    L. Plíšková
    Endocrine Pathology, 1998, 9 (2) : 149 - 155
  • [8] The role of conserved residues of chagasin in the inhibition of cysteine peptidases
    dos Reis, Flavia C. G.
    Smith, Brian O.
    Santos, Camila C.
    Costa, Tatiana F. R.
    Scharfstein, Julio
    Coombs, Graham H.
    Mottram, Jeremy C.
    Lima, Ana Paula C. A.
    FEBS LETTERS, 2008, 582 (04) : 485 - 490
  • [9] The immunohistochemical expression of BCL-2 oncoprotein in colorectal adenocarcinoma
    Ishijima, N
    Miki, C
    Ishida, T
    Kinoshita, T
    Suzuki, H
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 1999, 29 (07): : 682 - 684
  • [10] BCL-2 ONCOPROTEIN EXPRESSION IN HEPATOCELLULAR-CARCINOMA
    SUZUKI, K
    HAYASHI, N
    ITO, Y
    NAKASE, H
    NODA, K
    ARAI, Y
    ENOMOTO, N
    ARAI, K
    YAMADA, Y
    TANAKA, M
    YOSHIHARA, H
    YOSHIKAWA, K
    SASAKI, Y
    FUSAMOTO, H
    KAMADA, T
    GASTROENTEROLOGY, 1994, 106 (04) : A992 - A992